Europe — EMA

Onpattro (Patisiran)

Patisiran, the active ingredient in Onpattro, is a small interfering RNA (siRNA) therapeutic presented as a solution for intravenous infusion use.

Patisiran

Request sourcing

Pack/s

What is Patisiran?

Patisiran, the active ingredient in Onpattro, is a small interfering RNA (siRNA) therapeutic presented as a solution for intravenous infusion use. It treats hereditary transthyretin-mediated amyloidosis (hATTR) in adults — the disease of the nervous system and peripheral nerve damage caused by to ...

What is Patisiran used for?

Onprote...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →